INVO BIOSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.98 USD | -0.01% |
|
-28.47% | -27.41% |
| Apr. 18 | Top Premarket Decliners | MT |
| Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Presenter SpeechJohn Heerdink (Analysts)Good morning, everyone. This is John Heerdink. I'm th...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Companyâs flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the womanâs body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.98
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.41% | 2.69M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- Transcript : INVO Bioscience, Inc., NAYA Biosciences Inc. - Special Call
